[go: up one dir, main page]

NO20090972L - Pyrazolo[1,5-A]pyrimidiner, fremgangsmater, anvendelser og sammensetninger - Google Patents

Pyrazolo[1,5-A]pyrimidiner, fremgangsmater, anvendelser og sammensetninger

Info

Publication number
NO20090972L
NO20090972L NO20090972A NO20090972A NO20090972L NO 20090972 L NO20090972 L NO 20090972L NO 20090972 A NO20090972 A NO 20090972A NO 20090972 A NO20090972 A NO 20090972A NO 20090972 L NO20090972 L NO 20090972L
Authority
NO
Norway
Prior art keywords
pyrimidines
pyrazolo
compositions
methods
sleep
Prior art date
Application number
NO20090972A
Other languages
English (en)
Norwegian (no)
Inventor
Antonio Guglietta
Luis Anglada
Albert Palomer
Original Assignee
Ferrer Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ferrer Int filed Critical Ferrer Int
Publication of NO20090972L publication Critical patent/NO20090972L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Anesthesiology (AREA)
  • Pain & Pain Management (AREA)
  • Epidemiology (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO20090972A 2006-08-04 2009-03-03 Pyrazolo[1,5-A]pyrimidiner, fremgangsmater, anvendelser og sammensetninger NO20090972L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US83544406P 2006-08-04 2006-08-04
EP06118454A EP1884516A1 (fr) 2006-08-04 2006-08-04 Pyrazolo[1,5-a]pyrimidines, compositions pharmaceutiques les contenant et leur utilisation
PCT/EP2007/058006 WO2008015253A1 (fr) 2006-08-04 2007-08-02 Pyrazolo[1,5-a]pyrimidines, procédés, applications et compositions

Publications (1)

Publication Number Publication Date
NO20090972L true NO20090972L (no) 2009-04-30

Family

ID=37864479

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20090972A NO20090972L (no) 2006-08-04 2009-03-03 Pyrazolo[1,5-A]pyrimidiner, fremgangsmater, anvendelser og sammensetninger

Country Status (24)

Country Link
US (1) US8158632B2 (fr)
EP (2) EP1884516A1 (fr)
JP (1) JP2009545568A (fr)
KR (1) KR20090046916A (fr)
CN (1) CN101641359A (fr)
AR (1) AR062205A1 (fr)
AT (1) ATE469906T1 (fr)
AU (1) AU2007280412A1 (fr)
BR (1) BRPI0715169A2 (fr)
CA (1) CA2659969A1 (fr)
CL (1) CL2007002262A1 (fr)
CY (1) CY1110757T1 (fr)
DE (1) DE602007006966D1 (fr)
DK (1) DK2059521T3 (fr)
ES (1) ES2346810T3 (fr)
MX (1) MX2009001149A (fr)
NO (1) NO20090972L (fr)
PL (1) PL2059521T3 (fr)
PT (1) PT2059521E (fr)
RU (1) RU2458063C2 (fr)
SI (1) SI2059521T1 (fr)
TW (1) TW200815445A (fr)
UY (1) UY30521A1 (fr)
WO (1) WO2008015253A1 (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009095742A1 (fr) 2008-01-31 2009-08-06 Cellectis Nouvelle méganucléase à chaîne unique dérivée de l'i-crei et ses utilisations
WO2010053127A1 (fr) * 2008-11-05 2010-05-14 協和発酵キリン株式会社 Modulateur du récepteur α1-gabaa ou du récepteur α5-gabaa
ES2540867T3 (es) * 2010-02-26 2015-07-14 Mitsubishi Tanabe Pharma Corporation Compuestos de pirazolopirimidina y su uso como inhibidores de PDE10
CN102807569B (zh) * 2012-08-21 2015-02-25 四川大学 一种镇静催眠的化合物及其制备方法和用途

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4626538A (en) * 1983-06-23 1986-12-02 American Cyanamid Company [7-(3-disubstituted amino)phenyl]pyrazolo[1,5-a]pyrimidines
US4847256A (en) * 1986-10-16 1989-07-11 American Cyanamid Company 4,5-dihydro and 4,5,6,7-tetrahydropyrazolo(1,5-A)-pyrimidines
US6399621B1 (en) * 1999-08-10 2002-06-04 American Cyanamid Company N-methyl-N-(3-{3-[2-thienylcarbonyl]-pyrazol-[1, 5-α]-pyrimidin-7-yl}phenyl)acetamide and compositions and methods related thereto
ES2222813B1 (es) * 2003-07-24 2005-12-16 Ferrer Internacional, S.A. N-(3-(3-sustituidas-pirazolo(1,5-a)pirimidin-7-il)-fenil)-sulfonamidas y composiciones y metodos relacionados.
TWI252851B (en) * 2003-07-24 2006-04-11 Ferrer Int 7-substituted 3-nitro-pyrazolo[1,5-a]pyrimidines and compositions and methods related thereto
EP1736475A1 (fr) 2005-06-21 2006-12-27 Ferrer Internacional, S.A. Pyrazolo[1,5-a]pyrimidines halogenées, processus, utilisations, compositions et produits intermédiaires
DE102005028765B4 (de) * 2005-06-22 2016-01-21 Airbus Operations Gmbh Verfahren zur Herstellung eines Verstärkungsprofils
EP1956021A1 (fr) * 2006-10-11 2008-08-13 Ferrer Internacional, S.A. Procédé de préparation d'un pyrazole[1,5-a]pyrimidine en forme crystalline

Also Published As

Publication number Publication date
SI2059521T1 (sl) 2010-09-30
CA2659969A1 (fr) 2008-02-07
CN101641359A (zh) 2010-02-03
JP2009545568A (ja) 2009-12-24
RU2458063C2 (ru) 2012-08-10
PT2059521E (pt) 2010-08-26
BRPI0715169A2 (pt) 2013-06-11
EP2059521B1 (fr) 2010-06-02
US8158632B2 (en) 2012-04-17
HK1129105A1 (en) 2009-11-20
TW200815445A (en) 2008-04-01
UY30521A1 (es) 2008-02-29
KR20090046916A (ko) 2009-05-11
EP2059521A1 (fr) 2009-05-20
PL2059521T3 (pl) 2010-11-30
ATE469906T1 (de) 2010-06-15
MX2009001149A (es) 2009-03-02
US20090264448A1 (en) 2009-10-22
CL2007002262A1 (es) 2008-01-18
EP1884516A1 (fr) 2008-02-06
ES2346810T3 (es) 2010-10-20
RU2009107734A (ru) 2010-09-10
AR062205A1 (es) 2008-10-22
AU2007280412A1 (en) 2008-02-07
DE602007006966D1 (de) 2010-07-15
DK2059521T3 (da) 2010-09-27
CY1110757T1 (el) 2015-06-10
WO2008015253A1 (fr) 2008-02-07

Similar Documents

Publication Publication Date Title
MX2009010127A (es) Compuestos utiles como inhibidores de janus cinasas.
GEP20084550B (en) Substituted morpholine compounds for the treatment of central nervous system disorders
IL200793A0 (en) Aminopyrimidines, compositions comprising the same and use thereof for inhibiting protein kinases
MX2009010037A (es) Aminopirimidinas utiles como inhibidores de cinasas.
MX2009008253A (es) Derivados de 2-aminopiridina utiles como inhibidores de cinasa.
EA200801551A1 (ru) Применение сульфонамидных производных в лечении расстройств метаболизма и нервной системы
SG170828A1 (en) Deazapurines useful as inhibitors of janus kinases
ECSP077421A (es) Compuestos y composiciones como inhibidores de la actividad del receptor canabinoide 1
MX2009009590A (es) Aminopirimidinas utiles como inhibidores de proteinas cinasas.
TW200621736A (en) Mitotic kinesin inhibitors and methods of use thereof
TW200612905A (en) Novel sulfamate and sulfamide derivatives useful for the treatment of epilepsy and related disorders
TNSN08373A1 (en) Azolopyrimidines as inhibitors of cannabinoid 1 activity
MX2010006748A (es) Pirazolo[1,5-a]pirimidinas utiles como inhibidores de jak2.
MX2009011811A (es) Aminopirimidinas utiles como inhibidores de cinasa.
MX2009006345A (es) Compuestos utiles como inhibidores de proteina cinasa.
TW200611702A (en) Novel sulfamate and sulfamide derivatives useful for the treatment of epilepsy and related disorders
TW200800976A (en) New compounds for the treatment of neurological, psychiatric or pain disorders
MX2009004771A (es) Compuestos heteroaril triciclicos utiles como inhibidores de janus cinasa.
NO20084375L (no) Imidazo[1,2-B]pyridaziner, deres fremstilling og deres anvendelse som GABA reseptorligander
NO20080393L (no) Halogenerte pyrazolo [1,5-A] pyrimidiner, fremgangsmater, anvendelse som GABA-A reseptorligander, sammensetninger og intermediater
WO2009061924A3 (fr) Inhibiteurs aldh-2 dans le traitement de troubles psychiatriques
MX2009002842A (es) Inhibidores heterociclicos de c-met y usos de los mismos.
NO20090972L (no) Pyrazolo[1,5-A]pyrimidiner, fremgangsmater, anvendelser og sammensetninger
NO20072972L (no) Terapeutiske pyrazolo[3,4-B]pyridiner og indazoler
TW200745088A (en) Benzimidazoles useful as inhibitors of protein kinases

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application